Clinical trial
Study of Gemcitabine and Concurrent Radiation Followed by Adjuvant Hysterectomy…
NCT00184093 · University of Southern California, Other · Completed
Key facts
| NCT number | NCT00184093 |
|---|---|
| Title | Study of Gemcitabine and Concurrent Radiation Followed by Adjuvant Hysterectomy in Bulky Stage Ib and IIa Cervical Carcinoma |
| Official title | Phase I/II Study of Gemcitabine and Concurrent Radiation Followed by Adjuvant Hysterectomy in Bulky Stage Ib and IIa Cervical Carcinoma: Analysis of Prognostic Factors and Determinants of Response: A Pilot Study |
| Lead sponsor | University of Southern California, Other |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Uterine Cervical Cancer |
| Intervention type | Drug |
| Interventions | Gemcitabine |
| Enrollment | 35 |
| Start date | Jun 1, 1999 |
| Primary completion | May 1, 2008 |
| Completion | May 1, 2009 |
| First posted | Sep 16, 2005 |
| Last update posted | Aug 15, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: